Carlos Posadas-Romero Selected Research

Phosphodiesterase I (5' Exonuclease)

2/2015	Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
9/2014	IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.
1/2013	Single nucleotide polymorphisms within LIPA (Lysosomal Acid Lipase A) gene are associated with susceptibility to premature coronary artery disease. a replication in the genetic of atherosclerotic disease (GEA) Mexican study.
1/2012	The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Posadas-Romero Research Topics

Disease

16	Atherosclerosis 01/2019 - 04/2003
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 10/2006
11	Hypertension (High Blood Pressure) 01/2020 - 01/2010
10	Insulin Resistance 01/2020 - 10/2006
7	Acute Coronary Syndrome 01/2020 - 07/2011
6	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2007
6	Fatty Liver 01/2018 - 02/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2018 - 01/2008
5	Coronary Disease (Coronary Heart Disease) 09/2015 - 08/2004
4	Abdominal Obesity 01/2018 - 01/2010
4	Obesity 04/2017 - 06/2014
4	Inflammation (Inflammations) 01/2016 - 12/2008
3	Myocardial Infarction 01/2018 - 10/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2017 - 01/2010
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012 - 10/2006
3	Overweight 06/2011 - 10/2006
2	Hypertriglyceridemia 01/2018 - 01/2010
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 10/2015
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2013 - 11/2003
2	Hypothyroidism 04/2003 - 04/2002
1	Hypotension (Low Blood Pressure) 01/2020
1	Coronary Restenosis 03/2019
1	Ischemic Stroke 01/2018
1	Diabetes Mellitus 01/2017
1	Chronic Renal Insufficiency 03/2016
1	Carotid Artery Diseases 08/2015
1	Hyperuricemia 09/2014
1	Essential Hypertension 01/2013
1	Proteinuria 12/2012
1	Hepatocellular Carcinoma (Hepatoma) 03/2012
1	Cardiovascular Abnormalities 06/2011

Drug/Important Bio-Agent (IBA)

13	HDL CholesterolIBA 01/2021 - 08/2004
8	AdiponectinIBA 01/2020 - 03/2012
8	CholesterolIBA 01/2018 - 04/2003
7	Insulin (Novolin)FDA Link 04/2017 - 01/2004
7	LipidsIBA 01/2016 - 10/2006
6	Triglycerides (Triacylglycerol)IBA 01/2017 - 06/2011
5	Proteins (Proteins, Gene)FDA Link 07/2018 - 11/2003
5	HDL LipoproteinsIBA 01/2018 - 04/2002
5	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 02/2007
4	CytokinesIBA 01/2018 - 11/2014
4	Phosphodiesterase I (5' Exonuclease)IBA 02/2015 - 01/2012
3	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2018 - 09/2014
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2015
3	oxidized low density lipoproteinIBA 03/2016 - 01/2004
3	Nonesterified Fatty Acids (NEFA)IBA 01/2016 - 02/2015
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2015 - 10/2006
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2015 - 04/2002
3	Lipoproteins (Lipoprotein)IBA 06/2011 - 11/2003
2	lipoprotein cholesterolIBA 01/2020 - 06/2014
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2002
2	Interleukin-27 (Interleukin 27)IBA 01/2019 - 09/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 07/2011
2	Lipoprotein(a)IBA 01/2018 - 11/2003
2	InterleukinsIBA 11/2017 - 01/2017
2	LDL CholesterolIBA 01/2017 - 03/2012
2	CreatinineIBA 09/2016 - 12/2012
2	Lipase (Acid Lipase)FDA Link 02/2015 - 04/2003
2	Alkaline PhosphataseIBA 01/2015 - 09/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2011 - 01/2004
1	branched-chain-amino-acid transaminaseIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Uric Acid (Urate)IBA 03/2019
1	DefensinsIBA 01/2019
1	E-SelectinIBA 01/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Interleukin-15 (Interleukin 15)IBA 11/2017
1	H-cadherin (T-cadherin)IBA 10/2017
1	Alanine Transaminase (SGPT)IBA 10/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	AdipokinesIBA 01/2017
1	Interleukin-33IBA 01/2017
1	AlbuminsIBA 09/2016
1	DiureticsIBA 03/2016
1	MagnesiumIBA 03/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2015
1	CC ChemokinesIBA 10/2015
1	Monocyte Chemoattractant ProteinsIBA 10/2015
1	C-Reactive ProteinIBA 09/2015
1	Biological ProductsIBA 08/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2015
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	CarbohydratesIBA 01/2015
1	C-Type Lectins (C-Type Lectin)IBA 12/2014
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 06/2014
1	Endothelins (Endothelin)IBA 06/2014
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2013
1	EnzymesIBA 01/2013
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2012
1	Angiotensin IIIBA 03/2012
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2012

Therapy/Procedure

1	Stents 03/2019
1	Glycemic Control 09/2013